1. Du, Xinna, Shen, Xuan, Dai, Li, Zhang, Hu, Lu, Chunfeng. 2020. PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes. In Biochemical and biophysical research communications, 526, 368-374. doi:10.1016/j.bbrc.2020.03.095. https://pubmed.ncbi.nlm.nih.gov/32222279/
2. Ma, Jia, Zhou, Wenyang, Yuan, Yifeng, Wang, Baosheng, Meng, Xiangpeng. 2023. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression. In Cancer gene therapy, 30, 1072-1083. doi:10.1038/s41417-023-00609-y. https://pubmed.ncbi.nlm.nih.gov/37037907/
3. Li, Xiaocheng, Qiao, Ming, Zhou, Yan, Xie, Chenchen, Zhang, Yamei. 2024. Modulating the RPS27A/PSMD12/NF-κB pathway to control immune response in mouse brain ischemia-reperfusion injury. In Molecular medicine (Cambridge, Mass.), 30, 106. doi:10.1186/s10020-024-00870-3. https://pubmed.ncbi.nlm.nih.gov/39039432/
4. Gao, Feng, Wang, Zhengzheng, Gu, Jiajie, Zhang, Xiaojia, Wang, Huixiao. 2021. A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas. In Frontiers in oncology, 11, 726794. doi:10.3389/fonc.2021.726794. https://pubmed.ncbi.nlm.nih.gov/34868920/
5. Khalil, Raida, Kenny, Connor, Hill, R Sean, Walsh, Christopher A, Chahrour, Maria H. 2018. PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 177, 736-745. doi:10.1002/ajmg.b.32688. https://pubmed.ncbi.nlm.nih.gov/30421579/
6. Isidor, Bertrand, Ebstein, Frédéric, Hurst, Anna, Küry, Sébastien, Stankiewicz, PaweƗ. 2021. Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype. In Genetics in medicine : official journal of the American College of Medical Genetics, 24, 179-191. doi:10.1016/j.gim.2021.09.005. https://pubmed.ncbi.nlm.nih.gov/34906456/